The aim of this study was to evaluate the diagnostic performance of PAX1 methylation in detecting cervical lesions, including HSIL and cervical squamous cell carcinoma (CSCC), by using real-time PCR in a clinical cohort. This evidence concerns the gene PAX1 and skin squamous cell carcinoma.